Arzneimittel mit dem Wirkstoff Midazolam (ATC: N03AE02)

TENDER DESCRIPTION

Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for finished medicinal products containing the active substance Midazolam (ATC: N03AE02) with the possibility to conclude at any time within the framework of a so-called "open-house model." A contract is concluded with every pharmaceutical company that meets the participation requirements. No exclusivity is granted. Joining or contract conclusion can take place at any time and under the same conditions. Individual contract negotiations will not be conducted. The earliest contract start date is 01.09.2026. Based on this, the contract duration is a maximum of 24 months. The contract ends on 31.08.2028 regardless of the contract start date. If AOK Sachsen-Anhalt awards exclusivity contracts for the active substances during the contract term in accordance with the relevant procurement law provisions, the contracts concluded under this publication will be terminated in accordance with the contractual provisions. This publication does not constitute the award of a public contract within the meaning of § 103 GWB or procurement law. To ensure a high degree of transparency for the intended contract…

TENDER BRIEF

TENDER DOCUMENTS